Personensuche
Personensuche
Es wurde 1 Person gefunden.
E-Mail
Funktionen
-
Mitglied/er, Promotionsausschuss
-
Universitätsprofessor/in, Klinik für Erkrankungen des vorderen Augenabschnittes
Aktuelle Veranstaltungen
-
WiSe 2025
- Repetitorium für das 2. Staatsexamen (WA)
- Klinische Visite (Kinderophthalmologie und Strabologie) (WA)
- Praktikum der Augenheilkunde (PV)
- Ausbildung im dritten klinischen Studienabschnitt (PJ WP)
- Vorlesung Augenheilkunde (WA)
- Spezielle Augenheilkunde (WA)
- Kurs der allgemeinen klinischen Untersuchung im nichtoperativen und operativen Stoffgebiet - Augenuntersuchungskurs (PV)
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
- Ausbildung im dritten klinischen Studienabschnitt (PJ WP)
- Praktikum der Augenheilkunde (PV)
- Klinische Visite (Kinderophthalmologie und Strabologie) (WA)
- Kurs der allgemeinen klinischen Untersuchung im nichtoperativen und operativen Stoffgebiet - Augenuntersuchungskurs (PV)
- Repetitorium für das 2. Staatsexamen (WA)
- Spezielle Augenheilkunde (WA)
- Vorlesung Augenheilkunde (WA)
-
WiSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Alterations in ganglion cell and nerve fiber layer in Leber hereditary optic neuropathy across clinical stagesIn: BMC Ophthalmology, Jg. 25, 2025, Nr. 1, 183DOI (Open Access)
-
Angeborene Dakryozystozelen bei Säuglingen : Langzeitergebnisse nach minimalinvasiver endoskopischer endonasaler TherapieIn: Klinische Monatsblätter für Augenheilkunde, Jg. 24, 2025, Nr. 03, S. 240 – 244
-
Assessment of disease activity in Graves’ orbitopathyIn: Frontiers in Ophthalmology, Jg. 5, 2025, 1697892DOI (Open Access)
-
Orbital Floor Fractures in Germany : Interdisciplinary Care without a Uniform Standard - Results of a Multicentre SurveyIn: Klinische Monatsblätter für Augenheilkunde, Jg. 242, 2025, Nr. 9, S. 927 – 934
-
Real world effectiveness of Mycophenolate-sodium therapy in patients at risk with Graves’ orbitopathyIn: Thyroid Research, Jg. 18, 2025, Nr. 1, 46DOI (Open Access)
-
Endokrine Orbitopathie als Ursache einer Diplopie im Senium : Unterschiede zwischen Jung und AltIn: Die Ophthalmologie, Jg. 121, 2024, S. 548 – 553
-
Evaluation of a Retinal Projection Laser Eyeware in Patients with Visual Impairment Caused by Corneal Diseases in a Randomized TrialIn: Ophthalmology, Jg. 131, 2024, Nr. 5, S. 545 – 556DOI (Open Access)
-
How Age Affects Graves’ Orbitopathy : A Tertiary Center StudyIn: Journal of Clinical Medicine (JCM), Jg. 13, 2024, Nr. 1, 290DOI (Open Access)
-
MR Imaging Characteristics of Solitary Fibrous Tumors of the Orbit : Case Series of 18 PatientsIn: Clinical Neuroradiology, Jg. 34, 2024, Nr. 3, S. 605 – 611DOI (Open Access)
-
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)In: British Journal of Ophthalmology (BJO), Jg. 108, 2024, Nr. 2, S. 294 – 300DOI (Open Access)
-
Solitär fibröse Tumoren der Orbita : klinisch-pathologische Charakteristik, Therapie und PrognoseIn: Klinische Monatsblätter für Augenheilkunde, Jg. 241, 2024, Nr. 01, S. 15 – 29
-
Treatment Outcomes of Patients with Orbital Inflammatory Diseases : Should Steroids Still Be the First Choice?In: Journal of Clinical Medicine (JCM), Jg. 13, 2024, Nr. 14, 3998DOI, Online Volltext (Open Access)
-
Aktuelle Therapieansätze der endokrinen Orbitopathie - sind die zielgerichteten Therapien die Zukunft?In: Klinische Monatsblätter für Augenheilkunde, Jg. 241, 2023, Nr. 1, S. 48 – 68
-
Endokrine Orbitopathie : Aktueller Stand der medikamentösen TherapieIn: Laryngo-Rhino-Otologie, Jg. 102, 2023, Nr. 3, S. 177 – 185
-
Evaluation of [⁶⁸Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital SpaceIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 8, S. 1185 – 1190DOI (Open Access)
-
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy : The INDIGO Multicenter European StudyIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 108, 2023, Nr. 8, S. 2065 – 2077DOI (Open Access)
-
Incidence of A pattern strabismus after inferior rectus recession in patients with Graves' orbitopathy : A retrospective multicentre studyIn: Acta Ophthalmologica, Jg. 101, 2023, Nr. 1, S. e106 – e112DOI (Open Access)
-
Influence of biological sex, age and smoking on Graves’ orbitopathy : A ten-year tertiary referral center analysisIn: Frontiers in Endocrinology, Jg. 14, 2023, 1160172DOI (Open Access)
-
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye diseaseIn: Frontiers in Endocrinology, Jg. 14, 2023, 1211473DOI (Open Access)
-
Long-Term Follow-Up of Patients with Conjunctival Lymphoma after Individualized Lens-Sparing Electron Radiotherapy : Results from a Longitudinal StudyIn: Cancers, Jg. 15, 2023, Nr. 22, 5433DOI (Open Access)
-
Low-dose AtropIne for Myopia Control in Children (AIM) : protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel armsIn: BMJ Open, Jg. 13, 2023, Nr. 4, S. e068822DOI (Open Access)
-
MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy : imaging remission criteria and volumetric regression kineticsIn: Scientific Reports, Jg. 13, 2023, Nr. 1, 4792DOI, Online Volltext (Open Access)
-
Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' OrbitopathyIn: Endocrinology, Jg. 164, 2023, Nr. 2, bqac203DOI (Open Access)
-
Management of carotid cavernous fistulas : a single center experienceIn: Frontiers in Neurology, Jg. 14, 2023, 1123139DOI, Online Volltext (Open Access)
-
Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye diseaseIn: Frontiers in Endocrinology, Jg. 14, 2023, 1252727DOI (Open Access)
-
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye DiseaseIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 108, 2023, Nr. 12, S. 3122 – 3134DOI (Open Access)
-
Radioiodine Ablation of Thyroid Remnants in Patients with Graves' OrbitopathyIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 4, S. 561 – 566DOI (Open Access)
-
Sphingolipids in thyroid eye diseaseIn: Frontiers in Endocrinology, Jg. 14, 2023, 1170884DOI (Open Access)
-
2022 European Thyroid Association Guideline for the management of pediatric Graves’ diseaseIn: European Thyroid Journal, Jg. 11, 2022, Nr. 1, e210073DOI (Open Access)
-
An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' OrbitopathyIn: Thyroid, Jg. 32, 2022, Nr. 3, S. 283 – 293
-
Evaluation of Orbital Lymphoproliferative and Inflammatory Disorders by Gene Expression AnalysisIn: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 15, 8609DOI, Online Volltext (Open Access)
-
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy : Results from a longitudinal studyIn: Hematological Oncology, Jg. 40, 2022, Nr. 5, S. 922 – 929DOI (Open Access)
-
Novel Insights into Pathophysiology of Orbital Inflammatory Diseases and Progression to Orbital Lymphoma by Pathway Enrichment AnalysisIn: Life, Jg. 12, 2022, Nr. 10, 1660DOI (Open Access)
-
Proposing a surgical algorithm for graduated orbital decompression in patients with Graves’ orbitopathyIn: European Archives of Oto-Rhino-Laryngology and Head & Neck, Jg. 279, 2022, Nr. 5, S. 2401 – 2407DOI (Open Access)
-
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment : OPTIC-X StudyIn: Ophthalmology, Jg. 129, 2022, Nr. 4, S. 438 – 449DOI (Open Access)
-
The Biology of Ocular Adnexal Marginal Zone LymphomasIn: Cancers, Jg. 14, 2022, Nr. 5, 1264DOI, Online Volltext (Open Access)
-
18 F-FDG-PET/MRI in patients with Graves’ orbitopathyIn: Graefes Archive for Clinical and Experimental Ophthalmology, Jg. 259, 2021, Nr. 10, S. 3107 – 3117DOI (Open Access)
-
Bony Orbital Decompression in Patients with High Myopia and PseudoexophthalmosIn: Klinische Monatsblätter für Augenheilkunde, Jg. 238, 2021, Nr. 1, S. 41 – 47
-
First Use of a New Robotic Endoscope Guiding System in Endoscopic Orbital DecompressionIn: Ear, Nose & Throat Journal, Jg. 100, 2021, Nr. 5 Suppl., S. 443S – 448SDOI (Open Access)
-
Graves' orbitopathyIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 146, 2021, Nr. 20, S. 1344 – 1351
-
Graves' orbitopathy : Current concepts for medical treatmentIn: Klinische Monatsblätter für Augenheilkunde, Jg. 238, 2021, Nr. 1, S. 24 – 31
-
Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced diseaseIn: Microbiome, Jg. 9, 2021, Nr. 1, 45DOI (Open Access)
-
Orbital aspergillosis : A case report and review of the literatureIn: BMC Ophthalmology, Jg. 21, 2021, Nr. 1, 22DOI, Online Volltext (Open Access)
-
Orbital exenteration : Symptoms, indications, tumour localizations, pathologies, reconstruction, complications and survivalIn: Journal of Cranio-Maxillofacial Surgery, Jg. 49, 2021, Nr. 8, S. 659 – 669
-
Predicting the Course of Graves’ Orbitopathy Using Serially Measured TSH-Receptor Autoantibodies by Automated Binding Immunoassays and the Functional BioassayIn: Hormone and Metabolic Research, Jg. 53, 2021, Nr. 07, S. 435 – 443DOI (Open Access)
-
Predicting the Relapse of Hyperthyroidism in Treated Graves’ Disease with Orbitopathy by Serial Measurements of TSH-Receptor AutoantibodiesIn: Hormone and Metabolic Research, Jg. 53, 2021, Nr. 4, S. 235 – 244DOI (Open Access)
-
Primary and secondary superior rectus recessions to correct vertical deviations in Graves’ orbitopathy patientsIn: Acta Ophthalmologica, Jg. 99, 2021, Nr. 8, S. 850 – 860DOI (Open Access)
-
Risk Factors for New Onset Diplopia After Graduated Orbital DecompressionIn: Ophthalmic Plastic and Reconstructive Surgery, Jg. 37, 2021, Nr. 6, S. 564 – 570
-
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathyIn: European Journal of Endocrinology (EJE), Jg. 185, 2021, Nr. 4, S. G43 – G67DOI (Open Access)
-
Yokoyama procedure for esotropia associated with high myopia : Real-world data from a large-scale multicentre analysisIn: Acta Ophthalmologica, Jg. 99, 2021, Nr. 8, S. e1340 – e1347DOI (Open Access)
-
Asymmetry indicates more severe and active disease in Graves’ orbitopathy : results from a prospective cross-sectional multicentre studyIn: Journal of Endocrinological Investigation, Jg. 43, 2020, Nr. 12, S. 1717 – 1722DOI (Open Access)
-
First evaluation of a retinal imaging laser eyewear system based low vision aidIn: Clinical Ophthalmology, Jg. 14, 2020, S. 4115 – 4123DOI, Online Volltext (Open Access)
-
Further evidence for POMK as candidate gene for WWS with meningoencephaloceleIn: Orphanet Journal of Rare Diseases, Jg. 15, 2020, 242DOI (Open Access)
-
Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the malt subtype by whole genome, whole exome and targeted sequencingIn: Cancers, Jg. 12, 2020, Nr. 4, 986DOI, Online Volltext (Open Access)
-
Lessons from mouse models of Graves’ diseaseIn: Endocrine, Jg. 68, 2020, Nr. 2, S. 265 – 270DOI (Open Access)
-
Modulating TSH Receptor Signaling for Therapeutic BenefitIn: European Thyroid Journal, Jg. 9, 2020, Nr. Suppl. 1, S. 66 – 77DOI (Open Access)
-
Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathyIn: Folia Histochemica et Cytobiologica, Jg. 1, 2020, Nr. 1, S. 37 – 45DOI (Open Access)
-
Teprotumumab for the treatment of active thyroid eye diseaseIn: The New England Journal of Medicine, Jg. 382, 2020, Nr. 4, S. 341 – 352DOI (Open Access)
-
Visual rehabilitation of patients with corneal diseasesIn: BMC Ophthalmology, Jg. 20, 2020, 184DOI (Open Access)
-
A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' OrbitopathyIn: Thyroid, Jg. 29, 2019, Nr. 1, S. 111 – 123
-
A comparative analysis of piezosurgery and oscillating saw for balanced orbital decompressionIn: Orbit, Jg. 38, 2019, Nr. 6, S. 433 – 439
-
Aktuelle Therapiekonzepte bei oberflächlichen malignen TumorenIn: Laryngo-Rhino-Otologie, Jg. 98, 2019, Nr. 10, S. 685 – 694
-
Evaluation der Versorgungssituation von Sehbehinderten : Signifikante Unterschiede zwischen Jung und AltIn: Die Ophthalmologie, Jg. 116, 2019, Nr. 2, S. 164 – 171
-
Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone ReceptorIn: Thyroid, Jg. 29, 2019, Nr. 9, S. 1286 – 1301
-
Immunotherapy with fingolimod improves outcome of experimental Graves disease and associated orbitopathy by modulating autoimmune response to thyroid stimulating hormone receptorIn: Investigative Ophthalmology & Visual Science (IOVS), Jg. 60, 2019, Nr. 9
-
Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves’ orbitopathyIn: PLoS ONE, Jg. 14, 2019, Nr. 6, S. e0218701DOI (Open Access)
-
MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activationIn: Journal of Autoimmunity, Jg. 96, 2019, S. 94 – 103
-
Aktuelle Therapiekonzepte bei oberflächlichen malignen TumorenIn: Klinische Monatsblätter für Augenheilkunde, Jg. 235, 2018, Nr. 10, S. 1138 – 1147
-
CD40 Enhances Sphingolipids in Orbital Fibroblasts : Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves' OrbitopathyIn: Investigative Ophthalmology & Visual Science (IOVS), Jg. 59, 2018, Nr. 13, S. 5391 – 5397DOI (Open Access)
-
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathyIn: Scientific Reports, Jg. 8, 2018, Nr. 1, S. 8386DOI (Open Access)
-
Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathyIn: Clinical and Experimental Immunology, Jg. 191, 2018, Nr. 3, S. 255 – 267DOI (Open Access)
-
Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse modelIn: Scientific Reports, Jg. 8, 2018, S. 13096DOI, Online Volltext (Open Access)
-
Gut Microbiome in BALB/c and C57BL/6J Mice Undergoing Experimental Thyroid Autoimmunity Associate with Differences in Immunological Responses and Thyroid FunctionIn: Hormone and Metabolic Research, Jg. 50, 2018, Nr. 12, S. 932 – 941DOI, Online Volltext (Open Access)
-
Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of diseaseIn: Microbiome, Jg. 6, 2018, Nr. 1, 97DOI (Open Access)
-
Korrektur horizontaler Schielwinkel nach Dekompressionsoperation bei Patienten mit endokriner Orbitopathie - Vergleich von Sehnenverlängerung und einfacher Rücklagerung des M. rectus medialisIn: Klinische Monatsblätter für Augenheilkunde, Jg. 235, 2018, Nr. 10, S. 1105 – 1114
-
Multimodal assessment of orbital immune cell infiltration and tissue remodeling during development of graves disease by ¹H¹⁹F MRIIn: Magnetic Resonance in Medicine, Jg. 80, 2018, Nr. 2, S. 711 – 718
-
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO) : a randomised, observer-masked, multicentre trialIn: The Lancet Diabetes and Endocrinology, Jg. 6, 2018, Nr. 4, S. 287 – 298
-
Noninflammatory diffuse follicular hypertrophy/hyperplasia of graves disease : Morphometric evaluation in an experimental mouse modelIn: European Thyroid Journal, Jg. 7, 2018, Nr. 3, S. 111 – 119DOI (Open Access)
-
Surgical Treatment of Diplopia in Graves Orbitopathy PatientsIn: Ophthalmic Plastic and Reconstructive Surgery, Jg. 34, 2018, Nr. 4S Suppl.1, S. S75 – S84
-
Tendon Elongation with Bovine Pericardium in Patients with Severe Esotropia after Decompression in Graves’ Orbitopathy : efficacy and Long-term StabilityIn: Strabismus, Jg. 26, 2018, Nr. 2, S. 62 – 70
-
The influence of orbital decompression on objective nasal function in patients with graves’ orbitopathyIn: European Archives of Oto-Rhino-Laryngology and Head & Neck, Jg. 275, 2018, Nr. 10, S. 2507 – 2513
-
Umgang mit gerinnungshemmenden Substanzen in der Ophthalmochirurgie : eine Umfrage unter Ophthalmochirurgen in DeutschlandIn: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Jg. 115, 2018, Nr. 7, S. 585 – 591
-
Combination Therapy of Intravenous Steroids and Orbital Irradiation is More Effective Than Intravenous Steroids Alone in Patients with Graves' OrbitopathyIn: Hormone and Metabolic Research, Jg. 49, 2017, Nr. 10, S. 739 – 747
-
Das endoskopische Browlift mittels Endotine Forehead Device bei FazialispareseIn: Laryngo-Rhino-Otologie, Jg. 96, 2017, Nr. 10, S. 691 – 697
-
Graves’ orbitopathy as a rare disease in Europe : a European Group on Graves’ Orbitopathy (EUGOGO) position statementIn: Orphanet Journal of Rare Diseases, Jg. 12, 2017, Nr. 1, S. 72DOI (Open Access)
-
Outcome of a graduated minimally invasive facial reanimation in patients with facial paralysisIn: European Archives of Oto-Rhino-Laryngology and Head & Neck, Jg. 274, 2017, Nr. 8, S. 3241 – 3249
-
Reducing Diplopia in patients with graves orbitopathy - efficacy of intravenous glucocorticoids with and without combination of orbital radiotherapyIn: Investigative Ophthalmology & Visual Science (IOVS), Jg. 58, 2017, Nr. 8, -
-
Comparative assessment of female mouse model of Graves' orbitopathy under different environments, accompanied by proinflammatory cytokine and T-cell responses to thyrotropin hormone receptor antigenIn: Endocrinology, Jg. 157, 2016, Nr. 4, S. 1673 – 1682DOI (Open Access)
-
Endokrine OrbitopathieIn: Klinische Monatsblätter für Augenheilkunde, Jg. 233, 2016, Nr. 12, S. 1385 – 1407
-
Endokrine OrbitopathieIn: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Jg. 113, 2016, Nr. 4, S. 349 – 366
-
Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for SmokingIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 101, 2016, Nr. 12, S. 4834 – 4842
-
Lack of Association between Selenium Status and Disease Severity and Activity in Patients with Graves' OphthalmopathyIn: European Thyroid Journal, Jg. 5, 2016, Nr. 1, S. 57 – 64
-
Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse ModelIn: Endocrinology, Jg. 157, 2016, Nr. 10, S. 3771 – 3778
-
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomasIn: OncoTarget, Jg. 7, 2016, Nr. 38, S. 62627 – 62639DOI (Open Access)
-
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyIn: European Thyroid Journal, Jg. 5, 2016, Nr. 1, S. 9 – 26
-
The Effect of Early Thyroidectomy on the Course of Active Graves' Orbitopathy (GO) : A Retrospective Case StudyIn: Hormone and Metabolic Research, Jg. 48, 2016, Nr. 7, S. 433 – 439
-
Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathyIn: Mediators of Inflammation, 2015, 340934DOI (Open Access)
-
Erratum: Modeling Graves' Orbitopathy in Experimental Graves' DiseaseIn: Hormone and Metabolic Research, Jg. 47, 2015, Nr. 10, S. e4
-
Modeling Graves' Orbitopathy in Experimental Graves' DiseaseIn: Hormone and Metabolic Research, Jg. 47, 2015, Nr. 10, S. 797 – 803
-
Orbital fibroblasts from graves' orbitopathy patients share functional and immunophenotypic properties with mesenchymal stem/stromal cellsIn: Investigative Ophthalmology & Visual Science (IOVS), Jg. 56, 2015, Nr. 11, S. 6549 – 6557DOI (Open Access)
-
PREGO (presentation of Graves’ orbitopathy) study : changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012In: British Journal of Ophthalmology (BJO), Jg. 99, 2015, Nr. 11, S. 1531 – 1535
-
Prinzip Gegenparese: M.-obliquus-inferior-Rücklagerung bei Patienten mit endokriner OrbitopathieIn: Klinische Monatsblätter für Augenheilkunde, Jg. 232, 2015, Nr. 10, S. 1178 – 1183
-
FGFβ and TGFβ contribute to tissue remodeling, fibrosis and inflammation in the orbital tissue of severe GravIn: Acta Ophthalmologica, Jg. 92, 2014, Nr. S253: Special Issue: Abstracts from the 2014 European Association for Vision and Eye Research Conference, 8645
-
Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves' Orbitopathy : Clinical ImplicationsIn: Mediators of Inflammation, 2014, 412158DOI (Open Access)
-
Okuläre Myopathien und AutoimmunitätIn: Klinische Monatsblätter für Augenheilkunde, Jg. 231, 2014, Nr. 9, S. e47 – e67
-
Okuläre Myopathien und AutoimmunitätIn: Augenheilkunde up2date, Jg. 4, 2014, Nr. 3, S. 215 – 233
-
Autoantibodies to the IGF1 receptor in graves' orbitopathyIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 98, 2013, Nr. 2, S. 752 – 760
-
Current Insights into Animal Models of Graves’ Disease and OrbitopathyIn: Hormone and Metabolic Research, Jg. 45, 2013, Nr. 8, S. 549 – 555
-
Examination of orbital tissues in murine models of graves' disease reveals expression of UCP-1 and the TSHR in retrobulbar adipose tissuesIn: Hormone and Metabolic Research, Jg. 45, 2013, Nr. 6, S. 401 – 407
-
GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21In: Oncogene, Jg. 32, 2013, Nr. 38, S. 4557 – 4564
-
Update endokrine OrbitopathieIn: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Jg. 110, 2013, Nr. 11, S. 1079 – 1096
-
Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude miceIn: Endocrinology, Jg. 153, 2012, Nr. 4, S. 2034 – 2042DOI (Open Access)
-
A Novel Mechanism Involved in the Pathogenesis of Graves Ophthalmopathy (GO) : Clathrin Is a Possible Targeting Molecule for Inhibiting Local Immune Response in the OrbitIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 96, 2011, Nr. 11, S. E1727 – 1736
-
Course of pattern-reversed visual evoked cortical potentials in 30 eyes after bony orbital decompression in dysthyroid optic neuropathyIn: British Journal of Ophthalmology (BJO), Jg. 95, 2011, Nr. 2, S. 222 – 226
-
Durch eine kleine temporale Tarsorrhaphie lässt sich der Effekt der Unterlidverlängerung mit Implantat bei Patienten einer Endokrinen Orbitopathie signifikant steigernIn: Klinische Monatsblätter für Augenheilkunde, Jg. 228, 2011, Nr. 10, S. 887 – 891
-
Endokrine OrbitopathieIn: Klinische Monatsblätter für Augenheilkunde, Jg. 228, 2011, Nr. 5, S. 432 – 438
-
Endokrine Orbitopathie : M.-rectus-inferior-Sehnenverlängerung bei großen vertikalen Schielwinkeln, die nicht durch eine einfache Muskelrücklagerung korrigiert werden könnenIn: Klinische Monatsblätter für Augenheilkunde, Jg. 228, 2011, Nr. 10, S. 880 – 886
-
Is minimally invasive, video-assisted thyroidectomy feasible in Graves' disease?In: Surgery, Jg. 149, 2011, Nr. 4, S. 556 – 560
-
Operative Therapie bei endokriner OrbitopathieIn: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Jg. 108, 2011, Nr. 5, S. 432 – 439
-
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathyIn: Graefes Archive for Clinical and Experimental Ophthalmology, Jg. 248, 2010, Nr. 1, S. 103 – 109
-
Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathyIn: Pediatric Endocrinology Reviews, Jg. 7, 2010, Nr. Suppl. 2, S. 198 – 203
-
Reproducibility of Elecsys®Anti-TSHR Test Results in a Lot-to-Lot ComparisonIn: Hormone and Metabolic Research, Jg. 42, 2010, Nr. 4, S. 295 – 297
-
Superior oblique tucking with versus without additional inferior oblique recession for acquired trochlear nerve palsyIn: Graefes Archive for Clinical and Experimental Ophthalmology, Jg. 248, 2010, Nr. 2, S. 223 – 229
-
Thyrotropin receptor autoantibodies are independent risk factors for graves' ophthalmopathy and help to predict severity and outcome of the diseaseIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 91, 2006, Nr. 9, S. 3464 – 3470DOI, Online Volltext (Open Access)
-
Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodiesIn: Clinical Endocrinology, Jg. 61, 2004, Nr. 5, S. 612 – 618
-
Dry eye syndrome in thyroid-associated ophthalmopathy : Lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodiesIn: Acta Ophthalmologica Scandinavica, Jg. 82, 2004, Nr. 3p1, S. 291 – 297DOI (Open Access)
-
EditorialIn: Klinische Monatsblätter für Augenheilkunde. Stuttgart: Thieme, Jg. 238, 2021, Nr. 1, S. 22 – 23
-
Linsenschonende Elektronenbestrahlung bei konjunktivalen Non-Hodgkin Lymphomen : Monozentrische Langzeitdaten zur Efektivität und NebenwirkungenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S106DOI (Open Access)
-
Treatment with linsitinib, an IGF-1 receptor inhibitor, attenuates disease development and progression in an experimental model of Graves’ Orbitopathy
Immunology 2023 ; May 11 - 15, 2023, Washington, DC, USA,In: The Journal of Immunology (JI). Minneapolis: American Association of Immunologists, Jg. 210, 2023, Nr. Supplement 1: Immunology 2023 Meeting Abstracts, 165.13 -
Long-term Follow-Up in Patients with Stage IAE Orbital Lymphoma and Radiotherapy with Photons : Monocentric ResultsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 58 – S59
-
18F-FDG -PET/MRI in patients with Graves’ orbitopathy
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S251 – S252DOI (Open Access) -
Biopsy of orbital inflammation
European Association for Vision and Eye Research Conference, 4–6 October 2018 Nice, France,In: Acta Ophthalmologica. Oxford: Wiley-Blackwell - STM, Jg. 96, 2018, Nr. S261: Special Issue: Abstracts from the 2018 European Association for Vision and Eye Research Conference, S. 34 – 35DOI (Open Access) -
Clinical Value of the First Automated TSH Receptor Autoantibody Assay for the Diagnosis of Graves' Disease : an International Multicenter Trial
184. Tagung der Rheinisch-Westfälischen Gesellschaft für Innere Medizin e.V., Düsseldorf, 19.-21.11.2009,In: Medizinische Klinik. Berlin: Springer, Jg. 105, 2010, Nr. 3, S. 214 -
Surgical Management of Extraocular Muscle Dysfunction in Patients with GOIn: Graves’ Disease: A Comprehensive Guide for Clinicians / Bahn, Rebecca S. (Hrsg.). New York: Springer New York, 2015, S. 287 – 299
-
Eyelid surgeryIn: Graves' Orbitopathy: A Multidisciplinary Approach - Questions and Answers / Wiersinga, Wilmar M.; Kahaly, George J.: S. Karger, 2010, S. 200 – 210
-
Einfluss schilddrüsenspezifischer Antikörper und anderer Risikofaktoren auf den Verlauf der endrokrinen OrbitophatieDuisburg-Essen, 2004